• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质 G 蛋白偶联受体的晶体结构。

Crystal structure of a lipid G protein-coupled receptor.

机构信息

Receptos, 10835 Road to the Cure, San Diego, CA 92121, USA.

出版信息

Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904.

DOI:10.1126/science.1215904
PMID:22344443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3338336/
Abstract

The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors. Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P(1)-T4L) in complex with an antagonist sphingolipid mimic. Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor. Access is gained by ligands entering laterally between helices I and VII within the transmembrane region of the receptor. This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the molecular recognition and requirement for hydrophobic volume that activates S1P(1), resulting in the modulation of immune and stromal cell responses.

摘要

溶血磷脂神经鞘氨醇 1-磷酸通过激活 G 蛋白偶联神经鞘氨醇 1-磷酸受体调节淋巴细胞迁移、内皮细胞发育和完整性、心率以及血管张力和成熟。在此,我们展示了与拮抗剂鞘脂类似物结合的融合 T4 溶菌酶的神经鞘氨醇 1-磷酸受体 1(S1P(1)-T4L)的晶体结构。受体的氨基末端和细胞外环阻塞了结合口袋的细胞外进入。配体通过进入受体跨膜区域的 I 螺旋和 VII 螺旋之间的横向进入来获得进入。该结构以及诱变、激动剂结构-活性关系数据和建模,提供了 S1P(1)激活的分子识别和疏水性体积要求的详细视图,从而调节免疫和基质细胞反应。

相似文献

1
Crystal structure of a lipid G protein-coupled receptor.脂质 G 蛋白偶联受体的晶体结构。
Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904.
2
Structure of the first sphingosine 1-phosphate receptor.首个神经酰胺 1-磷酸受体结构。
Sci Signal. 2012 May 22;5(225):pe23. doi: 10.1126/scisignal.2003160.
3
FTY720 (Gilenya) phosphate selectivity of sphingosine 1-phosphate receptor subtype 1 (S1P1) G protein-coupled receptor requires motifs in intracellular loop 1 and transmembrane domain 2.FTY720(吉仑他滨)对鞘氨醇 1-磷酸受体亚型 1(S1P1)G 蛋白偶联受体的磷酸选择性需要细胞内环 1 和跨膜域 2 中的基序。
J Biol Chem. 2011 Sep 2;286(35):30513-30525. doi: 10.1074/jbc.M111.263442. Epub 2011 Jun 30.
4
A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor.单个氨基酸决定了对磷脂的偏好,并揭示了S1P4受体激活的长度限制。
BMC Biochem. 2004 Aug 6;5:12. doi: 10.1186/1471-2091-5-12.
5
Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations.从微秒全原子分子动力学模拟中得出的脂质受体 S1P₁激活方案。
PLoS Comput Biol. 2013;9(10):e1003261. doi: 10.1371/journal.pcbi.1003261. Epub 2013 Oct 3.
6
Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.1-磷酸鞘氨醇(S1P)受体S1P1和S1P3之间配体结合口袋形状的差异决定了通过超高通量筛选鉴定化学探针的效率。
ACS Chem Biol. 2008 Aug 15;3(8):486-98. doi: 10.1021/cb800051m. Epub 2008 Jul 1.
7
S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.高通量筛选得到的S1P1选择性体内活性激动剂:受体相互作用、信号传导及命运的现成化学探针
Chem Biol. 2005 Jun;12(6):703-15. doi: 10.1016/j.chembiol.2005.04.019.
8
Agonist-dependent effects of mutations in the sphingosine-1-phosphate type 1 receptor.激动剂依赖性效应:鞘氨醇-1-磷酸 1 型受体突变的影响。
Eur J Pharmacol. 2011 Sep 30;667(1-3):105-12. doi: 10.1016/j.ejphar.2011.05.071. Epub 2011 Jun 6.
9
Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.1-磷酸鞘氨醇受体1(S1P1)疏水配体结合口袋的鉴定。
J Biol Chem. 2007 Jan 26;282(4):2374-85. doi: 10.1074/jbc.M609648200. Epub 2006 Nov 18.
10
Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors.在内皮分化基因受体家族中,鞘氨醇-1-磷酸类似物对S1P4的识别及选择性
Biochem J. 2005 Jul 1;389(Pt 1):187-95. doi: 10.1042/BJ20050046.

引用本文的文献

1
Crystal structures of agonist-bound human cannabinoid receptor CB.激动剂结合型人大麻素受体CB的晶体结构
Nature. 2025 Aug 27. doi: 10.1038/s41586-025-09454-5.
2
Efficient Characterization of GPCRs Allosteric Modulation: Application to the Rational Design of De Novo S1PR1 Allosteric Modulators.G蛋白偶联受体变构调节的高效表征:在从头设计S1PR1变构调节剂的合理设计中的应用。
J Chem Inf Model. 2025 Aug 25;65(16):8637-8652. doi: 10.1021/acs.jcim.5c01163. Epub 2025 Aug 4.
3
Mapping previously undetected trees reveals overlooked changes in pan-tropical tree cover.

本文引用的文献

1
Crystal structure of the β2 adrenergic receptor-Gs protein complex.β2 肾上腺素能受体-Gs 蛋白复合物的晶体结构。
Nature. 2011 Jul 19;477(7366):549-55. doi: 10.1038/nature10361.
2
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.激动剂结合的腺苷 A2A 受体结构揭示了 G 蛋白偶联受体激活的共同特征。
Nature. 2011 May 18;474(7352):521-5. doi: 10.1038/nature10136.
3
Structure of an agonist-bound human A2A adenosine receptor.激动剂结合的人 A2A 腺苷受体结构。
绘制先前未被发现的树木分布图揭示了泛热带树木覆盖中被忽视的变化。
Nat Commun. 2025 Jul 1;16(1):5561. doi: 10.1038/s41467-025-60662-z.
4
How the ghrelin receptor recognizes the acyl-modified orexigenic hormone.胃饥饿素受体如何识别酰基修饰的食欲素激素。
Front Mol Neurosci. 2025 Apr 7;18:1549366. doi: 10.3389/fnmol.2025.1549366. eCollection 2025.
5
Regulation of CXCR4 function by S1P through heteromerization.鞘氨醇-1-磷酸(S1P)通过异源二聚化对CXCR4功能的调节。
Cell Commun Signal. 2025 Feb 26;23(1):111. doi: 10.1186/s12964-025-02099-x.
6
S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity.S1PR1偏向性激活通过维持内皮完整性驱动与内皮功能障碍相关的炎症性疾病的消退。
Nat Commun. 2025 Feb 20;16(1):1826. doi: 10.1038/s41467-025-57124-x.
7
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2.鞘氨醇-1-磷酸转运体SPNS2的转运与抑制
Nat Commun. 2025 Jan 16;16(1):721. doi: 10.1038/s41467-025-55942-7.
8
Structural insights into the high basal activity and inverse agonism of the orphan receptor GPR6 implicated in Parkinson's disease.对与帕金森病相关的孤儿受体GPR6的高基础活性和反向激动作用的结构见解。
Sci Signal. 2024 Dec 3;17(865):eado8741. doi: 10.1126/scisignal.ado8741.
9
Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist.假性不可逆抑制引发了鞘氨醇 1-磷酸受体 1 拮抗剂的持久疗效。
Nat Commun. 2024 Jul 19;15(1):5743. doi: 10.1038/s41467-024-49893-8.
10
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.G 蛋白偶联受体-配体构象和功能分类预测。
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
Science. 2011 Apr 15;332(6027):322-7. doi: 10.1126/science.1202793. Epub 2011 Mar 10.
4
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.β2 肾上腺素能受体的纳米体稳定的活性状态结构。
Nature. 2011 Jan 13;469(7329):175-80. doi: 10.1038/nature09648.
5
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.人源多巴胺 D3 受体与 D2/D3 选择性拮抗剂复合物的结构。
Science. 2010 Nov 19;330(6007):1091-5. doi: 10.1126/science.1197410.
6
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.芬戈莫德(FTY720):一种治疗多发性硬化症的口服药物的发现和开发。
Nat Rev Drug Discov. 2010 Nov;9(11):883-97. doi: 10.1038/nrd3248. Epub 2010 Oct 29.
7
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.小分子和环肽拮抗剂与 CXCR4 趋化因子 GPCR 的结构。
Science. 2010 Nov 19;330(6007):1066-71. doi: 10.1126/science.1194396. Epub 2010 Oct 7.
8
A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor.配体结合的脂质途径对于大麻素 G 蛋白偶联受体是必需的。
J Biol Chem. 2010 Jun 4;285(23):17954-64. doi: 10.1074/jbc.M109.041590. Epub 2010 Mar 10.
9
Sphingosine 1-phosphate receptor signaling.鞘氨醇-1-磷酸受体信号传导
Annu Rev Biochem. 2009;78:743-68. doi: 10.1146/annurev.biochem.78.072407.103733.
10
A ligand channel through the G protein coupled receptor opsin.一种通过G蛋白偶联受体视蛋白的配体通道。
PLoS One. 2009;4(2):e4382. doi: 10.1371/journal.pone.0004382. Epub 2009 Feb 5.